Showing results (701-710 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|April 29, 2017
Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKOREYvonne Benešová, Aleš Tvaroh
Therapeutic Advances in Neurological Disorders|June 2, 2018
Danger signals in stroke and their role on microglia activation after ischemiaEileen Gülke, Mathias Gelderblom, Tim Magnus
Therapeutic Advances in Neurological Disorders|June 27, 2020
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)Francesco Patti, Andrea Visconti, Antonio Capacchione, et al.
Therapeutic Advances in Neurological Disorders|July 12, 2012
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairmentCarrie Hersh, Alex Rae-Grant
Therapeutic Advances in Neurological Disorders|July 12, 2012
Current and emerging therapies in multiple sclerosis: a systematic reviewWanda Castro-Borrero, Donna Graves, Teresa C Frohman, et al.
Therapeutic Advances in Neurological Disorders|July 12, 2012
Current and future medical treatment in primary dystoniaCathérine C S Delnooz, Bart P C van de Warrenburg
Therapeutic Advances in Neurological Disorders|May 15, 2023
Could statin improve outcomes after pipeline embolization for intracranial aneurysms in a real-world setting?Xinrui Wang, Mirzat Turhon, Xinjian Yang, et al.
Therapeutic Advances in Neurological Disorders|March 2, 2023
Short-term outcome prediction for myasthenia gravis: an explainable machine learning modelHuahua Zhong, Zhe Ruan, Chong Yan, et al.
Therapeutic Advances in Neurological Disorders|August 12, 2022
Dual anti-platelet therapy for secondary prevention in intracranial atherosclerotic disease: a network meta-analysisGiuseppe Reale, Aurelia Zauli, Giuseppe La Torre, et al.
Therapeutic Advances in Neurological Disorders|August 15, 2022
Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in JapanToshiyuki Hayashi, Shunya Nakane, Akihiro Mukaino, et al.
Pageof 108